Topics
Diffuse midline glioma | Treatment | Targeted therapy | Vorasidenib
Home > Publications > Topics > Diffuse midline glioma > Treatment > Targeted therapy > Vorasidenib
Kim H, Gomez A, Dixit KS.
First
report of a clinical and radiologic response to vorasidenib in a
patient with isocitrate dehydrogenase-mutant brainstem
astrocytoma.
Neurooncol
Pract. 2025 Dec 31;13(2):428-431. doi:
10.1093/nop/npaf131. PMID:
42111031˰ ˍ